<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00875290</url>
  </required_header>
  <id_info>
    <org_study_id>GerberPumpStudy</org_study_id>
    <nct_id>NCT00875290</nct_id>
  </id_info>
  <brief_title>The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children</brief_title>
  <acronym>Gerber RTSA</acronym>
  <official_title>Gerber Pump Trial: Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Real-Time Sensor Augmentation (RTSA) in 0-3 Years Old Diabetes Patients; A One Year Randomized Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seattle Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Gerber Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seattle Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if the use of a real-time glucose sensor improves
      diabetes control in young children (less than 4 years old) with Type I diabetes when they are
      initiated on insulin pump therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized controlled clinical trial involving patients 0-3 yrs old with type 1 diabetes.
      After successful screening the subjects will be randomized into one of two groups: a CSII
      group alone and a CSII group + Real Time Sensor Augmentation group (RTSA) group. The CSII
      group will serve as the control for the CSII+RTSA group. The trial will last for one year.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduce blood glucose variability among 0-3 year old children with type I diabetes.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of adverse events</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Diabetes Mellitus, Type I</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Observational arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Real-time glucose sensor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects wear real-time glucose sensor</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Real-time glucose sensor</intervention_name>
    <description>Children assigned to this intervention will use a real-time sensor continuously</description>
    <arm_group_label>Real-time glucose sensor</arm_group_label>
    <other_name>Minimed Paradigm Real-time sensor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children less than 4 years of age with Type I diabetes for at least 3 months

        Exclusion Criteria:

          -  Children greater than 4 years of age

          -  Monogenic diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Fechner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seattle Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patricia Fechner, M.D.</last_name>
    <phone>206-987-5037</phone>
    <email>patricia.fechner@seattlechildrens.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joyce Yi-Frazier, Ph.D.</last_name>
    <phone>206-987-5037</phone>
    <email>joyce.yi-frazier@seattlechildrens.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2009</study_first_submitted>
  <study_first_submitted_qc>April 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2009</study_first_posted>
  <last_update_submitted>August 4, 2011</last_update_submitted>
  <last_update_submitted_qc>August 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>Patricia Fechner, M.D.</name_title>
    <organization>Seattle Children's Hospital</organization>
  </responsible_party>
  <keyword>Diabetes Mellitus, Type I</keyword>
  <keyword>Children</keyword>
  <keyword>Insulin pump therapy</keyword>
  <keyword>Continuous glucose monitor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

